A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Clinical trial NCT04921111 · UNKNOWN

Trial details

NCT number: NCT04921111
Sponsor: Sinocelltech Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HPV Infection Vaccine Safety SCT1000

Start date: 2021-07-02
Primary completion: 2022-07-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.